SEC Charges Former CEO of Biotech Company CytoDyn with Fraud, Insider Trading

SEC Charges Former CEO of Biotech Company CytoDyn with Fraud, Insider Trading

Dec 20, 2022

The Securities and Exchange Commission today charged Nader Pourhassan, the former CEO of CytoDyn Inc., with fraud and insider trading in connection with providing misleading information to shareholders about the progress of a clinical research treatment…

Full report at: Read More

More News

WSH&B ANNOUNCES DEFENSE VERDICT FOR ST. JOHN’S HEALTH CENTER IN MEDICAL MALPRACTICE CIVIC TRIAL

VA services 10K loans in last year for Veterans borrowing from their life insurance policies

SEC Issues New Strategic Plan for Diversity, Equity, Inclusion, and Accessibility

Final Rule Published For Some Employment-Based Immigrant, Non-Immigrant Visa Programs

Secretary Raimondo Statement on Swiss-U.S. Data Privacy Framework

Former Social Security Administration Employee Indicted and Arrested for $1.8 Million Theft of Social Security Funds

SEC Chair Gensler to Depart Agency on January 20

FROM:

Ready, Set, Action! Our Sun is the Star in Dazzling Simulation

FROM:

CHIPS for America Announces up to $300 million in Funding to Boost U.S. Semiconductor Packaging

FROM:

SEC Charges Three Senior Executives in Two Actions Alleging Massive Bribery Scheme Involving Indian Energy Companies Adani Green and Azure Power

FROM: